Guanxiang Biotechnology's IPO

Guanxiang Biotechnology raised a round of funding on November 10, 2017. Investors include Public.

新疆冠翔生物科技股份有限公司, dba Guanxiang Biotechnology (冠翔生物) (NEEQ: 872329), is engaged in the R&D and production of in-vitro diagnostic (IVD) equipment, reagents, consumable…

Articles about Guanxiang Biotechnology's IPO: